Want to join the conversation?
$BABY, the maker of medical device for newborn care, reported a rise in 3Q16 earnings driven by lower provision for income tax expense, despite a fall in revenue. Net income rose to $13.16MM or $0.40 per share from $10.93MM or $0.33 per share last year. Revenue fell to $90.91MM from $94.58MM. Non-GAAP EPS was flat with last year at $0.39.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)